topic report
National Breast Cancer Awareness Month pink ribbon
Favicon Fierce Biotech

After Enhertu: The slow hunt for next-gen HER2 breast cancer drugs

From dual-payload ADCs to bispecifics and radioligands, drugmakers are hunting for answers either after Enhertu progression or to replace it.
Angus Liu Oct 28, 2026 9:00am
drug prices drug price increase

Apellis buyout fuels Biogen's best quarter since 2020

Oct 28, 2026 11:54am
GSK

GSK talks through Hibsago launch as it reports out mixed Q3

Oct 28, 2026 11:05am
Lilly

Lilly combines global markets under new leadership role

Oct 28, 2026 11:05am
Miels

GSK vows not to ‘park crap on Page 41’ in transparency push

Oct 28, 2026 10:14am
puzzle pieces merger and acquisition business concept

Consulting firm Blue Matter picks up comms agency Cognite

Oct 28, 2026 10:06am
More News

Amgen hit with FDA warning letter for ‘misleading’ video

Oct 28, 2026 9:42am

Supernus taps snowboarder Chloe Kim in new Qelbree push

Oct 28, 2026 8:30am

Eversana picks up London-based AI firm Estima Scientific

Oct 28, 2026 8:00am
Fierce Biotech

GSK plans ‘some limited impact’ to UK roles from restructuring

Oct 28, 2026 6:33am